425: Strive CMO Reposts Merger Update with Semler Scientific

Strive's Chief Marketing Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and associated risks.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are engaged in a proposed business combination.
• The communication, reposted by Strive's CMO, Arshia Sarkhani, on December 4, 2025, serves as a cautionary statement regarding forward-looking statements related to the merger.
• Forward-looking statements include expectations for strategic and financial benefits, the timing of the closing, and the successful integration of the combined businesses.
• The filing emphasizes that such statements are subject to inherent risks and uncertainties that could cause actual results to differ materially.
• Investors and stockholders are urged to read the Registration Statement on Form S-4, including the Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings before making any voting or investment decisions.

Sentiment

Score: 5

Explanation: The filing is a cautionary statement regarding a proposed merger, heavily emphasizing risks and uncertainties associated with forward-looking statements. While the underlying event (merger) is typically positive, the document's primary purpose is to highlight potential challenges and legal disclaimers, leading to a neutral-to-cautious sentiment.

Positives

• The proposed transaction is anticipated to yield strategic benefits for the combined company.
• The proposed transaction is expected to result in financial benefits for the combined company.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of either Strive or Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to conditions to closing not being received or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The future outlook for the combined Strive and Semler Scientific entity is characterized by anticipated strategic and financial benefits from the proposed transaction, including successful integration and improved financial performance. However, this outlook is subject to significant risks and uncertainties, including those related to the closing of the transaction, integration challenges, and market conditions.

Management Comments

• Arshia Sarkhani, Chief Marketing Officer of Strive, Inc., reposted the communication on X.com on December 4, 2025, in connection with the proposed business combination.

Industry Context

This announcement pertains to a specific business combination within the companies' respective industries. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests Strive's involvement or planned involvement in the digital asset space, which is a growing trend for some companies seeking alternative treasury management or investment strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is listed as a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock for the merger.
• Stockholders of Semler Scientific will need to approve the proposed transaction.
• Customers and employees of both companies may have adverse reactions or changes to business/employee relationships as a result of the announcement or completion of the transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and other relevant SEC documents when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy